Dent Disease Mutation Genotyping

Status Completed

Clinical Trial Summary

This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in Dent Disease.

Clinical Trial Description

During this study visit, the investigator will draw one tube, about two teaspoonfuls (1 to 1 ½ teaspoons for children), of blood from the subject's arm to obtain white blood cells. These white blood cells will be used as a source of DNA for genetic testing. The investigator will use the isolated DNA to try to identify the gene that is defective in Dent Disease by comparing it with the structure of genes in normal individuals, patients with Dent Disease, and family members for Dent Disease. ;

Study Design

Related Conditions & MeSH terms

Dent Disease

Clinical Trial Details

NCT number	NCT01783795
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	August 2012
Completion date	July 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02016235` - Role Of Phosphorus And FGF 23 In Patients With Dent Disease	Phase 1/Phase 2
Completed	`NCT02022189` - Review of Kidney Biopsies of Dent Disease Patients	N/A
Recruiting	`NCT06065852` - National Registry of Rare Kidney Diseases
Recruiting	`NCT02780297` - Prospective Research Rare Kidney Stones (ProRKS)
Recruiting	`NCT02026388` - Rare Kidney Stone Consortium Biobank
Completed	`NCT04459013` - Evaluation of the Release of Monomers From Composite Bonding Resins in Orthodontics
Not yet recruiting	`NCT06017193` - Ultrasound for Socket Healing Evaluation
Recruiting	`NCT00588562` - Rare Kidney Stone Consortium Patient Registry
Completed	`NCT02124395` - Health-related Quality of Life in Rare Kidney Stone